Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

2025年3月12日周三，Bio Techne（纳斯达克代码：TECH）参加了第27届巴克莱全球医疗保健会议。会议由巴克莱分析师Mahlouk Surguide和Bio Techne首席财务官Jim Hippel主持，探讨了公司在市场波动条件下的战略定位。尽管存在挑战，特别是在NIH资金方面，但Bio Techne对关键领域的增长前景保持乐观。

Bio-Techne蛋白科学部门总裁Will Geist表示，Leo系统有助于加速科学进步和下一代疗法的商业化进程。公司强调，早期采用者和测试者对系统在临床生物标志物研究、基因治疗效力检测和质量控制等多个应用领域的稳健性能和多功能性给予了积极评价。

Buy” on shares of Bio-Techne as a short-term investment idea. The firm expects Bio-Techne to report fiscal Q3 results in line or above ...

Techne (TECH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

Bio-Techne Corporation TECH recently began shipping the Leo System, powered by Simple Western Technology. Leo offers the throughput and precision of standard ELISAs in a fully automated western blot ...

StockNews.com cut shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a report issued on Monday morning. TECH has been the topic of a number of other research ...

Keybank National Association OH boosted its position in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 66.4% in the ...

Shares of Bio-Techne Corp. TECH rallied 1.55% to $64.37 Friday, on what proved to be an all-around great trading session for ...

The latest Techne UK weekly tracker poll suggests that Reform UK has hit a ceiling in support as Nigel Farage’s leadership is ...

Bio-Techne Corporation (NASDAQ: TECH) today announced that it has begun shipping the Leo™ System, powered by Simple Western™ Technology. Leo expands upon existing Simple Western platforms that offer ...